Member Login

E-mail / Login ID:

Password:





Not a member?

Forgot your password?

Are you a pet owner?

Find Information By:

Other Bayer Sites

Legend®

Legend® (hyaluronate sodium) is the only FDA approved I.V. and intra-articular therapy to treat equine non-infectious synovitis associated with osteoarthritis. "Legend is pure hyaluronate sodium, the same glycosaminoglycan present in normal joint fluid. Legend is produced by a patented biofermentation process, resulting in such purity that it can be given intravenously for immediate bioavailability.

Key Benefits

Legend, because of its unique purity, can be given intra-articularly or intravenously. I.V. administration provides the following advantages:

  • Safety
    • No need to invade the joint with a needle, risking bacterial entrance, physical trauma to joint tissues or intra-articular injection reactions.
    • Safety in breeding animals has not been determined.
    • Federal law restricts this drug to use by or on the order of a licensed veterinarian.
    • For use only in horses. Do not use in horses intended for human consumption.
  • Convenience
    • No shaving or surgical preparation of the joint.
    • IV administration to treat multiple joints.
    • Available in a larger, 20mL Multi Dose vial for Intravenous use only.
  • Efficacy
    • Proven to decrease inflammation and destructive enzymes associated with inflammation.1
    • Rapid onset of action. I.V. administration helps ensure a quick onset of action resulting in a rapid decrease in inflammation.
  • Applications
    • Legend 2mL, For Intravenous and Intra-Articular use
    • Legend 4mL, For Intravenous use only
    • Legend Multi 20mL, For Intravenous use only
      The intra-articular safety of Legend Multi dose with benzyl alcohol has not been determined.

Footnotes

  1. Kawcak, C.E., Frisbie, D.D., Trotter, G.W., McIlwraith, C.W., Gillette, S.M., Powers, B.E., Walton, R.M.: Effects of intravenous administration of hyaluronate sodium on carpal joins in exercising horses after arthroscopic surgery and osteochondral fragmentation. AJVR. Vol, 58, No. 10, October 1997.